Praxis Precision Medicines (PRAX)
(Delayed Data from NSDQ)
$40.54 USD
-3.29 (-7.51%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $40.49 -0.05 (-0.12%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Brokerage Reports
0 items in cart
Praxis Precision Medicines, Inc. [PRAX]
Reports for Purchase
Showing records 41 - 60 ( 101 total )
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Praxis'' Essential Tremor Program, Bent But Not Broken
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Sticking With The Sidelines, As PRAX-944 To Advance To Phase 3
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Praxis Unveils New Therapy Development Platforms Highlighting That There''s More Here Than Essential1; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Essentially Waiting - Essential1 Data On Track For 1Q23 As 4Q22 Results Post
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
HCW 2023 Top Picks: Seize the Opportunities
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Essential1 Readout Should Give Praxis Its Mojo Back; Raise PT to $16; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Essentially A Big Catalyst For PRAX - Ahead Of The PRAX-944/Essential1 Readout
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology - Feeling Busier than Usual? Revisiting Biotech Catalyst Activity
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
UCB Taps Praxis for Epilepsy Research Collaboration; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
A Little More Patience Needed, But Plenty to Look Forward; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
PRAX-222 Set to Move Ahead; PRAX-562 Hits Unexpected Speed Bump
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
PRAX-114 Falls Flat in Aria, Company Returns Focus on Epilepsy and Movement Disorders
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D